Objective To examine the effect of interventions used to enhance cognitive function in
patients experiencing cancer‐related cognitive impairment. Methods Studies including …

Objectives Cancer-related cognitive impairment (CRCI) refers to a cognitive decline
associated with cancer or its treatments. While research into CRCI is expanding, evidence …

Background Cognitive effects of tamoxifen have been described. We augment data from a
previous short-term (ST) follow-up study with long-term (LT) data to evaluate ST and LT …

Background Physical activity (PA) and reductions in sedentary behavior (SED) may mitigate
cancer-related cognitive impairment. The purpose of this study was to examine (a) the …

Introduction Tamoxifen is a common treatment for estrogen receptor-positive breast cancer.
While tamoxifen treatment is generally accepted as safe, there are concerns about adverse …

Background Cancer-related cognitive impairment (CRCI) is a common, persistent quality of
life complaint among breast cancer survivors (BCS), however there remain no proven …

Advances in diagnostic and therapeutic strategies have significantly contributed to an
increase in the survival rate of cancer patients. Recently, several studies suggested that …

随着癌症诊断与治疗水平的进步, 癌症患者生存率明显升高, 使得癌症及其治疗相关并发症逐渐
显现. 其中, 认知功能障碍可出现在癌症患者接受治疗前, 治疗期间甚至治疗后数年 …

Simple Summary Tamoxifen is prescribed to premenopausal patients with estrogen-receptor-
positive breast cancers for a period of 5–10 years after cancer diagnosis. This prolonged …

Cognitive changes following adjuvant treatment for breast cancer (BC) are well documented
following chemotherapy. However, limited studies have examined cognitive and/or …